Get started
Author

Fariborz Rakhshan Rohakhtar

Observed name: F. Rakshan Rohakhtar
Institution: Mayo Clinic
Observed institution: Mayo Clinic
OpenAlex ID: A5049276540
Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2015 · Stephen J. Murphy, Steven N. Hart, et al. · Cancer Research · 38
Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma
2015 · Alan R. Penheiter, Sibel Erdogan, et al. · BioMed Research International · 26
PDF
Regulator of G-protein signaling expression in human intestinal enteroendocrine cells and potential role in satiety hormone secretion in health and obesity
2024 · Alison N. McRae, Alexander L. Ticho, et al. · EBioMedicine · 8
A Protocol for the Cryopreservation of Human Intestinal Mucosal Biopsies Compatible With Single-Cell Transcriptomics and Ex Vivo Studies
2022 · Alison McRae, Maria Laura Ricardo-Silgado, et al. · Frontiers in Physiology · 7
PDF
Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphoma
2025 · Kun Yun, R. Leo Sakemura, et al. · Molecular Therapy Oncology · 4
Intrinsic Immunosuppressive Features of Monocytes Suppress CART19 through IL-1 Pathway Modulation in Mantle Cell Lymphoma
2024 · Kun Yun, R. Leo Sakemura, et al. · Blood
Data from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2023 · Stephen J. Murphy, Steven N. Hart, et al.
Data from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2023 · Stephen J. Murphy, Steven N. Hart, et al.
Supplemental Table 2 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2023 · Stephen J. Murphy, Steven N. Hart, et al.
Supplemental Figure Legeneds from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2023 · Stephen J. Murphy, Steven N. Hart, et al.
Supplemental Table 3 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2023 · Stephen J. Murphy, Steven N. Hart, et al.
Supplemental Figures and Table 1 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2023 · Stephen J. Murphy, Steven N. Hart, et al.
PDF
Supplemental Table 2 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2023 · Stephen J. Murphy, Steven N. Hart, et al.
Supplemental Figure Legeneds from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2023 · Stephen J. Murphy, Steven N. Hart, et al.
Supplemental Table 3 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2023 · Stephen J. Murphy, Steven N. Hart, et al.
Supplemental Figures and Table 1 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
2023 · Stephen J. Murphy, Steven N. Hart, et al.
A gene expression microarray-based diagnostic test appplied to patients with carcinoma of unknown primary (CUP)
2008 · F. Medeiros, C. P. Kolbert, et al. · Journal of Clinical Oncology
Works count: 17
Citation count: 83
H-index: 4
I10-index: 2
Year
Topic
Type